SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Vanessa J. Lavallard, Philippe Gual, Autophagy and Non-Alcoholic Fatty Liver Disease, BioMed Research International, 2014, 2014, 1

    CrossRef

  2. 2
    Peiwen Chen, Matilde Cescon, Paolo Bonaldo, Autophagy-mediated regulation of macrophages and its applications for cancer, Autophagy, 2014, 10, 2, 192

    CrossRef

  3. 3
    Elodie Viry, Jerome Paggetti, Joanna Baginska, Takouhie Mgrditchian, Guy Berchem, Etienne Moussay, Bassam Janji, Autophagy: An adaptive metabolic response to stress shaping the antitumor immunity, Biochemical Pharmacology, 2014, 92, 1, 31

    CrossRef

  4. 4
    Isao Okazaki, Takuji Noro, Nobuhiro Tsutsui, Eigoro Yamanouchi, Hajime Kuroda, Masayuki Nakano, Hiroaki Yokomori, Yutaka Inagaki, Fibrogenesis and Carcinogenesis in Nonalcoholic Steatohepatitis (NASH): Involvement of Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of Metalloproteinase (TIMPs), Cancers, 2014, 6, 3, 1220

    CrossRef

  5. 5
    G. D. Kennedy, M. Nukaya, S. M. Moran, E. Glover, S. Weinberg, S. Balbo, S. S. Hecht, H. C. Pitot, N. R. Drinkwater, C. A. Bradfield, Liver Tumor Promotion by 2,3,7,8-Tetrachlorodibenzo-p-dioxin Is Dependent on the Aryl Hydrocarbon Receptor and TNF/IL-1 Receptors, Toxicological Sciences, 2014, 140, 1, 135

    CrossRef

  6. 6
    Cheng Sun, Haoyu Sun, Cai Zhang, Zhigang Tian, NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma, Cellular and Molecular Immunology, 2014,

    CrossRef

  7. 7
    Badr Alzahrani, Tristan J. Iseli, Lionel W. Hebbard, Non-viral causes of liver cancer: Does obesity led inflammation play a role?, Cancer Letters, 2014, 345, 2, 223

    CrossRef

  8. 8
    Jia Liu, Lanhong Zheng, Leina Ma, Bin Wang, Youguang Zhao, Ning Wu, Ge Liu, Xiukun Lin, Oleanolic acid inhibits proliferation and invasiveness of Kras-transformed cells via autophagy, The Journal of Nutritional Biochemistry, 2014, 25, 11, 1154

    CrossRef

  9. 9
    Thomas C Wirth, Spontaneous and therapeutic immune responses in hepatocellular carcinoma: implications for current and future immunotherapies, Expert Review of Gastroenterology & Hepatology, 2014, 8, 1, 101

    CrossRef

  10. 10
    Ke Li, Xiao-Xi Lv, Fang Hua, Heng Lin, Wei Sun, Wen-Bin Cao, Xiao-Ming Fu, Jing Xie, Jiao-Jiao Yu, Zhe Li, Hong Liu, Ming-Zhe Han, Zhuo-Wei Hu, Targeting acute myeloid leukemia with a proapoptotic peptide conjugated to a toll-like receptor 2-mediated cell-penetrating peptide, International Journal of Cancer, 2014, 134, 3
  11. 11
    J-P Pradere, D H Dapito, R F Schwabe, The Yin and Yang of Toll-like receptors in cancer, Oncogene, 2014, 33, 27, 3485

    CrossRef

  12. 12
    Lingling Ji, Ruyi Xue, Wenqing Tang, Weibin Wu, Tingting Hu, Xijun Liu, Xiaomin Peng, Jianxin Gu, She Chen, Si Zhang, Toll like receptor 2 knock-out attenuates carbon tetrachloride (CCl4)-induced liver fibrosis by downregulating MAPK and NF-κB signaling pathways, FEBS Letters, 2014, 588, 12, 2095

    CrossRef

  13. 13
    Dan Hu, James Denney, Manfei Liang, Avani Javer, Xiaohua Yang, Ruiliang Zhu, Deling Yin, Stimulatory Toll-like receptor 2 suppresses restraint stress-induced immune suppression, Cellular Immunology, 2013, 283, 1-2, 18

    CrossRef

  14. 14
    Ziyan Wang, Jun Yan, Heng Lin, Fang Hua, Xiaoxing Wang, Hanzhi Liu, Xiaoxi Lv, Jiaojiao Yu, Su Mi, Jiaping Wang, Zhuo-Wei Hu, Toll-like receptor 4 activity protects against hepatocellular tumorigenesis and progression by regulating expression of DNA repair protein Ku70 in mice, Hepatology, 2013, 57, 5
  15. 15
    Erika Vacchelli, Alexander Eggermont, Catherine Sautès-Fridman, Jerome Galon, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi, Trial Watch, OncoImmunology, 2013, 2, 8, e25238

    CrossRef